World's Best Scientists 2026 revealed!
VIEW LIST
Don M. Benson

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 46 4593 4252 2071 1899 258 9943

Don M. Benson publications per year

The chart shows the history of publications by Don M. Benson between 1969 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Don M. Benson published across 58 years, from 1969 to 2026, averaging 5.6 papers a year. Output peaked at 43 publications in 2023. 5 of the 322 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1969 to 2026. Vertical axis: number of publications, 0 to 43. Peak 43 publications in 2023. 1969: 1 publication 1970: 0 publications 1971: 2 publications 1972: 2 publications 1973: 3 publications 1974: 3 publications 1975: 3 publications 1976: 2 publications 1977: 1 publication 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 1 publication 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 2 publications 1986: 0 publications 1987: 1 publication 1988: 3 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 1 publication 1997: 1 publication 1998: 0 publications 1999: 3 publications 2000: 0 publications 2001: 0 publications 2002: 0 publications 2003: 1 publication 2004: 1 publication 2005: 2 publications 2006: 3 publications 2007: 7 publications 2008: 6 publications 2009: 7 publications 2010: 17 publications 2011: 7 publications 2012: 16 publications 2013: 18 publications 2014: 18 publications 2015: 13 publications 2016: 20 publications 2017: 8 publications 2018: 15 publications 2019: 21 publications 2020: 20 publications 2021: 24 publications 2022: 14 publications 2023: 43 publications 2024: 7 publications 2025: 4 publications 2026: 1 publication
1969 2026

322 publications in total across all disciplines

View publications per year as a table
Don M. Benson: publications per year, 1969 to 2026
Year Publications
1969 1
1970 0
1971 2
1972 2
1973 3
1974 3
1975 3
1976 2
1977 1
1978 0
1979 0
1980 0
1981 1
1982 0
1983 0
1984 0
1985 2
1986 0
1987 1
1988 3
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 1
1997 1
1998 0
1999 3
2000 0
2001 0
2002 0
2003 1
2004 1
2005 2
2006 3
2007 7
2008 6
2009 7
2010 17
2011 7
2012 16
2013 18
2014 18
2015 13
2016 20
2017 8
2018 15
2019 21
2020 20
2021 24
2022 14
2023 43
2024 7
2025 4
2026 1
Total 322
Download as CSV

Don M. Benson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Don M. Benson sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 252–261 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 258 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148 258
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Don M. Benson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Don M. Benson sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 46–47 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192 46
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 1993 - Fellow of the American Phytopathological Society

Overview

Don M. Benson is affiliated with The Ohio State University in the United States and has a research focus primarily within the field of Medicine, with specialization in Hematology, Molecular Biology, Oncology, Transplantation, and Public Health, Environmental and Occupational Health. Their work spans multiple topics including Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation, Renal Transplantation Outcomes and Treatments, Acute Lymphoblastic Leukemia research, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, and Acute Myeloid Leukemia Research.

Benson has contributed to numerous publications with frequent outlets including Blood, Transplantation and Cellular Therapy, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, and Cancers.

The recent research papers authored or co-authored by Benson include:

  • Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function, 2021, JCI Insight
  • Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy, 2021, Journal of the National Comprehensive Cancer Network
  • Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation, 2021, Cancers
  • Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies, 2020, Journal of Geriatric Oncology
  • Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients, 2021, Frontiers in Oncology

Frequent co-authors collaborating with Benson are Ashley Rosko, Srinivas Devarakonda, Naresh Bumma, Yvonne A. Efebera, and Nidhi Sharma.

The scientist's work covers a range of subfields related to blood cancers, transplantation, and molecular mechanisms underlying disease and treatment responses. Their research includes focus areas such as early post-transplantation immunosuppression, functional deficits in older adults with hematologic malignancies, and immune regulation within tumor microenvironments.

Benson was honored as a Fellow of the American Phytopathological Society in 1993, indicating recognition within the scientific community.

Best Publications

  • The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

    Don M. Benson;Courtney E. Bakan;Anjali Mishra;Craig C. Hofmeister

  • Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.

    Jennifer R. Brown;John C. Byrd;Steven E. Coutre;Don M. Benson

  • Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

    Flavia Pichiorri;Flavia Pichiorri;Sung Suk Suh;Sung Suk Suh;Alberto Rocci;Luciana De Luca

  • CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

    Jianhong Chu;Youcai Deng;Don M. Benson;Shun He

  • Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells

    Francois Romagné;Pascale André;Pieter Spee;Stefan Zahn

  • Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC

    Shauna M. Collins;Courtney E. Bakan;Gina D. Swartzel;Craig C. Hofmeister

  • Pro- and Antiinflammatory Cytokine Signaling: Reciprocal Antagonism Regulates Interferon-gamma Production by Human Natural Killer Cells

    Jianhua Yu;Min Wei;Brian Becknell;Rossana Trotta

  • The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.

    Wenjuan Dong;Xiaojin Wu;Xiaojin Wu;Shoubao Ma;Shoubao Ma;Yufeng Wang

  • A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

    Norbert Vey;Jean-Henri Bourhis;Nicolas Boissel;Dominique Bordessoule

  • Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma

    Andrzej J. Jakubowiak;Don M. Benson;William Bensinger;David S.D. Siegel

  • A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.

    Don M. Benson;Craig C. Hofmeister;Swaminathan Padmanabhan;Attaya Suvannasankha

  • IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

    Don M. Benson;Courtney E. Bakan;Shuhong Zhang;Shauna M. Collins

  • Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.

    Ian W. Flinn;Brad S. Kahl;John P. Leonard;Richard R. Furman

  • A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.

    Thomas Martin;Rachid Baz;Don M. Benson;Nikoletta Lendvai;Nikoletta Lendvai

  • CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Demonstrates Clinical Activity and Pharmacodynamic Effects In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Richard R. Furman;John C. Byrd;Jennifer R Brown;Steven E. Coutre

  • A phase I trial of the anti-KIR antibody IPH2101 and lenalidomide in patients with relapsed/refractory multiple myeloma

    Don M. Benson;Adam D. Cohen;Sundar Jagannath;Nikhil C. Munshi

  • A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells

    Li Lin;Li Lin;Stephanie Deangelis;Elizabeth Foust;James Fuchs

  • Clinical Safety and Activity In a Phase 1 Study of CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, In Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

    Brad Kahl;John C. Byrd;Ian W. Flinn;Nina Wagner-Johnston

  • The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.

    Matthew A. Bill;James R. Fuchs;Chenglong Li;Jennifer Yui

  • CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

    Farrukh T. Awan;Rosa Lapalombella;Rossana Trotta;Jonathan P. Butchar

  • Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo–Expanded Autologous NK Cells

    Yufeng Wang;Yibo Zhang;Tiffany Hughes;Jianying Zhang

  • A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma

    Khuda D. Khan;Christos Emmanouilides;Don M. Benson;Deborah Hurst

  • The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells

    Tiffany Hughes;Edward L. Briercheck;Aharon G. Freud;Rossana Trotta

Frequent Co-Authors

Steven M. Devine
Steven M. Devine The Ohio State University
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Jianhua Yu
Jianhua Yu City Of Hope National Medical Center
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Jennifer R. Brown
Jennifer R. Brown Harvard University
Ian W. Flinn
Ian W. Flinn Sarah Cannon Research Institute
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Michael R. Grever
Michael R. Grever The Ohio State University
Steven Coutre
Steven Coutre Stanford University

External Links

Personal website of Don M. Benson

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees offer diverse career opportunities ranging from clinical practice to research. Accelerated Nursing programs such as absn programs with high acceptance rates provide a fast track to becoming a registered nurse, which can be an excellent stepping stone into immunology-related roles in patient care or clinical trials.

Entry-level nursing positions also have pathways that align well with immunology, with easy lpn programs to get into offering accessible options for gaining essential healthcare experience. These credentials allow professionals to engage directly with patients, enhancing understanding of immune-related conditions.

For advanced practice, pursuing a Family Nurse Practitioner degree can deepen clinical expertise. The easiest fnp program options often blend flexibility and quality, making them suitable for those balancing education with work. This specialization supports roles that involve immunological assessments and treatments.

Additionally, mental health is closely connected to the immune system, and online PMHNP degree programs can be pivotal. Exploring pmhnp programs online with best clinical placement ensures practical experience and a strong foundation for those interested in neuroimmunology or psychoneuroimmunology careers.

Best Scientists Citing Don M. Benson

Jianhua Yu

Jianhua Yu

City Of Hope National Medical Center

Publications: 68

Michael A. Caligiuri

Michael A. Caligiuri

City Of Hope National Medical Center

Publications: 60

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 56

John C. Byrd

John C. Byrd

University of Pittsburgh Cancer Institute

Publications: 49

Jennifer R. Brown

Jennifer R. Brown

Harvard University

Publications: 48

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 45

Jan A. Burger

Jan A. Burger

The University of Texas MD Anderson Cancer Center

Publications: 41

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 36

Sagar Lonial

Sagar Lonial

Emory University

Publications: 36

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 33

Tadeusz Robak

Tadeusz Robak

Medical University of Lodz

Publications: 33

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 32

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 32

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 31

Jeffrey S. Miller

Jeffrey S. Miller

University of Minnesota

Publications: 29

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 29

Trending Scientists

Satoru Kuhara

Satoru Kuhara

Kyushu University

Victor V. Solovyev

Victor V. Solovyev

Royal Holloway University of London

Mathieu Vandenbulcke

Mathieu Vandenbulcke

KU Leuven

Pascal Fries

Pascal Fries

Ernst Strüngmann Institute for Neuroscience

Meigen Zhang

Meigen Zhang

Chinese Academy of Sciences

Mark A. Moline

Mark A. Moline

University of Delaware

Kwang Chul Roh

Kwang Chul Roh

Korea Institute of Ceramic Engineering and Technology

Zhenyu Liu

Zhenyu Liu

Tsinghua University

Evangelos Trifon Laskaris

Evangelos Trifon Laskaris

General Electric (United States)

Kuo-Chun Chang

Kuo-Chun Chang

National Taiwan University

Yacine Challal

Yacine Challal

University of Doha for Science and Technology

Zheng Guo

Zheng Guo

Aarhus University

Valentin N. Parmon

Valentin N. Parmon

Russian Academy of Sciences

Victor M. Montori

Victor M. Montori

Mayo Clinic

Timothy C. Fabian

Timothy C. Fabian

University of Tennessee Health Science Center

Jing Liu

Jing Liu

Chongqing University

Related Immunology Rankings & Guides

2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus

2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus
2027 Best Master’s in Medical Science Programs

2027 Best Master’s in Medical Science Programs
2027 Best Direct-Entry Nurse Practitioner Programs

2027 Best Direct-Entry Nurse Practitioner Programs
2027 Best BSN to DNP Programs in Texas: Online & Campus

2027 Best BSN to DNP Programs in Texas: Online & Campus
2027 Best CNA to RN Degree Online Bridge Programs

2027 Best CNA to RN Degree Online Bridge Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Best Accelerated Healthcare Administration Degree Programs Online

2027 Best Accelerated Healthcare Administration Degree Programs Online
2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

2027 Best Accelerated Online Nurse Executive Leadership MSN Programs
2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs

2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs
2027 Best LPN Programs in Kansas – Accredited Online LPN Programs

2027 Best LPN Programs in Kansas – Accredited Online LPN Programs
2027 Best Accelerated Online Bachelor's in Health Sciences Programs

2027 Best Accelerated Online Bachelor's in Health Sciences Programs
2027 Best LVN Programs in Texas – Accredited Online LPN Programs

2027 Best LVN Programs in Texas – Accredited Online LPN Programs
2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs

2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs
2027 Best 6-Month LPN to RN Programs Online

2027 Best 6-Month LPN to RN Programs Online
2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference

2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference
2027 Best Medical Assistant Classes Online with Financial Aid

2027 Best Medical Assistant Classes Online with Financial Aid
September 2027 Best 1-Year Nurse Practitioner Online Programs

September 2027 Best 1-Year Nurse Practitioner Online Programs
2027 Best Accelerated Online Master of Health Administration (MHA) Programs

2027 Best Accelerated Online Master of Health Administration (MHA) Programs
2027 Best Accelerated LPN/LVN to BSN Online Bridge Programs

2027 Best Accelerated LPN/LVN to BSN Online Bridge Programs

Recently Published Articles

2027 Dental Assistant vs. Dental Hygienist: Explaining the Difference

2027 Dental Assistant vs. Dental Hygienist: Explaining the Difference
2027 Online Family Nurse Practitioner Degree Programs Costs: Tuition & Fees

2027 Online Family Nurse Practitioner Degree Programs Costs: Tuition & Fees
2027 Arizona MFT Licensing, Certifications, Careers and Requirements

2027 Arizona MFT Licensing, Certifications, Careers and Requirements
2027 How to Become an Urban Planner in Tennessee

2027 How to Become an Urban Planner in Tennessee
2027 What Can You Do with a Hospitality Management Degree: Costs & Job Opportunities

2027 What Can You Do with a Hospitality Management Degree: Costs & Job Opportunities
2027 Best LPN Programs in Georgia – Accredited Online LPN Programs

2027 Best LPN Programs in Georgia – Accredited Online LPN Programs
2027 How Long Does It Take to Earn an Online Business Administration Degree?

2027 How Long Does It Take to Earn an Online Business Administration Degree?
2027 Highest-Paying Jobs You Can Get With an Emergency Management Degree

2027 Highest-Paying Jobs You Can Get With an Emergency Management Degree
2027 Online Nurse Executive Leadership Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Nurse Executive Leadership Degree Programs With No Personal Statement or Admissions Essay Required
2027 Online Graphic Design Degree Programs Costs: Tuition & Fees

2027 Online Graphic Design Degree Programs Costs: Tuition & Fees
2027 How to Become an Urban Planner in Georgia

2027 How to Become an Urban Planner in Georgia
2027 Best Online Master’s Degree Programs in Psychology

2027 Best Online Master’s Degree Programs in Psychology
2027 Fastest Accredited Online Emergency Management Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online Emergency Management Programs: Accelerated Degrees and Completion Times
2027 Best Online Marine Science Degree Master's Programs for Working Professionals

2027 Best Online Marine Science Degree Master's Programs for Working Professionals
2027 Most Recession-Resistant Careers You Can Pursue With an Information Technology Degree

2027 Most Recession-Resistant Careers You Can Pursue With an Information Technology Degree
2027 Online Game Development Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Game Development Degree Programs With No Personal Statement or Admissions Essay Required
2027 Best Accelerated Online Associate Degree Programs

2027 Best Accelerated Online Associate Degree Programs
2027 Online Early Childhood Education Degree Programs Costs: Tuition & Fees

2027 Online Early Childhood Education Degree Programs Costs: Tuition & Fees
2027 How to Become a Blood Spatter Analyst

2027 How to Become a Blood Spatter Analyst
2027 Are There Any One-Year Online Environmental Science Degree Programs Worth Considering?

2027 Are There Any One-Year Online Environmental Science Degree Programs Worth Considering?
2027 EdS vs. EdD Degrees: Explaining the Difference

2027 EdS vs. EdD Degrees: Explaining the Difference